Education
About Us
Working with TipRanks
Follow Us
Ashland (ASH)
NYSE:ASH
ASH Stock Chart & Stats
$59.07
-$1.29(-1.81%)
At close: 4:00 PM EST
$59.07
-$1.29(-1.81%)
Day’s Range― - ―
52-Week Range$45.21 - $73.31
Previous CloseN/A
Volume49.57K
Average Volume (3M)1.01M
Market Cap
$2.70B
Enterprise Value$3.43B
Total Cash (Recent Filing)$207.00M
Total Debt (Recent Filing)$1.49B
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Feb 03, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend Yield2.79%
Share Statistics
EPS (TTM)1.08
Shares Outstanding45,762,100
10 Day Avg. Volume1,095,187
30 Day Avg. Volume1,014,382
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.16
Price to Sales (P/S)1.21
P/FCF Ratio-550.97
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit6.25
Enterprise Value/Ebitda-6.70
Forecast
1Y Price Target
$62.80Price Target Upside6.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)3.96
Revenue Forecast (FY)$1.87B
Bulls Say, Bears Say
Bulls Say
Innovation And GrowthGrowing prospects for ASH to accelerate growth tied to its innovation pipeline are expected to support earnings and multiple lift.
Management StrategyA potential activist in the stock is believed to enhance management’s focus on execution and value creation, resulting in an improved risk/reward.
Portfolio ManagementASH has largely cleaned up its portfolio and is firmly focused on improving costs while continuing to drive its innovation pillars for longer-term growth.
Bears Say
EBITDA RevisionA downward revision to EBITDA for Personal Care, Specialty Additives, and Intermediates primarily reflects lower volumes compared to prior outlook.
Market ChallengesThe end markets will continue to be a struggle, though believed to be less challenging than previously experienced.
Sales PerformanceSales came in a bit lighter than expected, down 8%, with 7% tied to the exiting of business.
Ashland News
ASH FAQ
What was Ashland’s price range in the past 12 months?
Ashland lowest stock price was $45.21 and its highest was $73.31 in the past 12 months.
What is Ashland’s market cap?
Ashland’s market cap is $2.70B.
When is Ashland’s upcoming earnings report date?
Ashland’s upcoming earnings report date is Feb 03, 2026 which is in 40 days.
How were Ashland’s earnings last quarter?
Ashland released its earnings results on Nov 04, 2025. The company reported $1.08 earnings per share for the quarter, missing the consensus estimate of $1.243 by -$0.163.
Is Ashland overvalued?
According to Wall Street analysts Ashland’s price is currently Undervalued.
Does Ashland pay dividends?
Ashland pays a Quarterly dividend of $0.415 which represents an annual dividend yield of 2.79%. See more information on Ashland dividends here
What is Ashland’s EPS estimate?
Ashland’s EPS estimate is 0.24.
How many shares outstanding does Ashland have?
Ashland has 45,762,100 shares outstanding.
What happened to Ashland’s price movement after its last earnings report?
Ashland reported an EPS of $1.08 in its last earnings report, missing expectations of $1.243. Following the earnings report the stock price went up 6.068%.
Which hedge fund is a major shareholder of Ashland?
Currently, no hedge funds are holding shares in ASH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ashland Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$62.80 (6.31% Upside)
$62.80 (6.31% Upside)
Blogger Sentiment
Bullish
ASH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 67.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.69%
12-Months-Change
Fundamentals
Return on Equity
-34.45%
Trailing 12-Months
Asset Growth
-18.32%
Trailing 12-Months
Company Description
Ashland
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
ASH Company Deck
ASH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Ashland demonstrated resilience in maintaining margins and achieving expected EBITDA despite sales declines driven by portfolio optimization. Successes in Life Sciences and Personal Care were notable, but challenges remain in the Intermediates segment and demand for coatings. Cash generation and liquidity are strong, but higher tax rates and delayed optimization benefits pose challenges.View all ASH earnings summariesASH Stock 12 Month Forecast
Average Price Target
$62.80
▲(6.31% Upside)
Technical Analysis
Ownership Overview
0.51% Insiders
29.86% Mutual Funds
20.59% Other Institutional Investors
25.90% Public Companies and
Individual Investors